My 3 top-performing ASX shares of 2022, and why I'm still buying 2 of them for 2023

Amid a tough year, some stocks managed to deliver positive returns.

| More on:
three men stand on a winner's podium with medals around their necks with their hands raised in triumph.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Fortescue was my strongest performer, as investors pushed it higher amid a rising iron ore price
  • My Duxton Water shares managed a positive return as water entitlement values held up despite heavy rainfall
  • The LIC L1 Long Short Fund’s share price managed a slight gain in 2022

A new year gives me the opportunity to review how things went in 2022. Some of my ASX shares managed gains, while others suffered double-digit losses. I'll be happy to buy more of two of them.

It was a very rough year for some sectors of the ASX share market. Inflation and the subsequent interest rate rises have sent some investors running for the exits, with a number of ASX tech shares and ASX retail shares down more than 50% over the past year, such as the Temple & Webster Group Ltd (ASX: TPW) share price.

While I'm not expecting most of 2023 to be like 2022, there could be more volatility ahead. Who knows what's going to happen next? That's part of the fun of investing.

Fortescue Metals Group Limited (ASX: FMG)

My best-performing ASX share was the ASX iron ore share, Fortescue. It rose by around 7% in 2022.

I think it must be pointed out that the timing of the start and end of the 12-month return has played a part here. If the 12-month comparison were done on 13 January, the Fortescue share price would have shown a decline, though if the 12-month return were calculated in it mid-December it would show an even better return than 7%.

Just over a year ago, the iron ore price had slumped to below US$100 per tonne, amid fears about the Chinese real estate sector, including Evergrande. Remember that? But then the Fortescue share price recovered through November and December 2021.

There has been another recovery through November 2022 for Fortescue, as China's COVID restrictions were removed. This could lead to an economic boost like we saw in western countries during 2022.

Not only did the Fortescue share price rise over the year, but it also paid a full-year dividend of A$2.07 per share, adding around 11% to the return (excluding franking credits).

Due to the strengthening iron ore price, I don't think I'm going to buy any more Fortescue shares unless there's a significant fall, which could be triggered by a drop in the iron ore price to below US$100 again.

Duxton Water Ltd (ASX: D2O)

This company owns water entitlements and leases them out to farmers on short-term or long-term contracts. The Duxton Water share price rose around 6% over 2022.

Despite the very heavy rainfall that southeast Australia has experienced over the last year, water values have held up well, despite there being an abundance of the commodity at the moment.

With La Nina (the wetter weather pattern) on track to end soon, this could mean less 'supply' of water and could mean higher prices. But, I'm not basing my investment interest on a guess about the weather or short-term water entitlement price movements.

I think water entitlements are a good way to get indirect exposure to the large food sector in Australia. Plus, the ASX water share can offer differentiated returns to the S&P/ASX 200 Index (ASX: XJO).

At the current Duxton Water share price, it's at a 14% discount to the post-tax net asset value (NAV). Plus, it's forecasting dividend growth for the next couple of years, so I will be looking to buy more of this stock in 2023.

L1 Long Short Fund Ltd (ASX: LSF)

This ASX share is a listed investment company (LIC) that invests in a mix of ASX shares and international shares.

It has the ability to 'short' shares – betting that a share price will go down – as well as invest normally. This can mean that it can deliver stable, or even positive, returns during volatile years like 2022.

But, I think it's worth saying that negative returns from its 'long' investments can still lead to negative overall returns – or the shorted shares can rise, which would also mean negative returns.

I'm looking to buy more shares of this LIC this year at a net tangible assets (NTA) discount in the high single digits or low double digits. I also like the idea of the growing dividend from this LIC.

Motley Fool contributor Tristan Harrison has positions in Duxton Water, Fortescue Metals Group, and L1 Long Short Fund. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia has recommended Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

a hand reaches out with australian banknotes of various denominations fanned out.
Dividend Investing

These 2 ASX dividend shares are great buys right now

These defensive names look like strong picks today.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Technology Shares

This ASX 200 share is being labelled one of the market's most undervalued by brokers

NextDC shares have pulled back sharply, but brokers believe the long-term growth story remains firmly on track.

Read more »

Hand holding out coal in front of a coal mine.
Energy Shares

Up 25% in 2025: Is Whitehaven Coal still a buy?

After a strong 25% run this year, investors are asking whether Whitehaven Coal still has more upside left.

Read more »

Five guys in suits wearing brightly coloured masks, they are corporate superheroes.
Opinions

5 ASX shares I'd buy with $10,000 this week

These are the ASX stocks I have my eye on this week.

Read more »

bull market model with a bull looking at a rising chart
Opinions

By December 2026, $1,000 invested in EOS shares could be worth…

With its share price taking off and contracts piling up, EOS is shaping up as one of the most compelling…

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »